Full Name
Bellinda King-Kallimanis PhD
Job Title
Director of Patient-Focused Research
Company
LUNGevity
Speaker Bio
Dr. King-Kallimanis has worked in patient-focused research for the past 17 years.
Prior to joining LUNGevity as Director of Patient-Focused Research, she worked at the US Food and Drug Administration Oncology Center of Excellence on the Patient Focused Drug Development team. There, Dr. King-Kallimanis worked on the development and launch of Project Patient Voice, a resource for patients and caregivers along with their healthcare providers to look at patient-reported symptom data collected from cancer clinical trials.
Dr. King-Kallimanis also has experience in industry and academia and has published over 60 peer reviewed papers that cover disease areas like lung cancer, depression, cognitive impairment and multiple sclerosis. She received her bachelor of social science and her master of science in applied statistics from Swinburne University of Technology in Melbourne, Australia, and her PhD in psychometrics from the Academic Medical Center in Amsterdam, Netherlands.
Prior to joining LUNGevity as Director of Patient-Focused Research, she worked at the US Food and Drug Administration Oncology Center of Excellence on the Patient Focused Drug Development team. There, Dr. King-Kallimanis worked on the development and launch of Project Patient Voice, a resource for patients and caregivers along with their healthcare providers to look at patient-reported symptom data collected from cancer clinical trials.
Dr. King-Kallimanis also has experience in industry and academia and has published over 60 peer reviewed papers that cover disease areas like lung cancer, depression, cognitive impairment and multiple sclerosis. She received her bachelor of social science and her master of science in applied statistics from Swinburne University of Technology in Melbourne, Australia, and her PhD in psychometrics from the Academic Medical Center in Amsterdam, Netherlands.
